DEPOMED INC's ticker is DEPO and the CUSIP is 249908104. A total of 209 filers reported holding DEPOMED INC in Q2 2016. The put-call ratio across all filers is 0.15 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $541,000 | +1.3% | 81,148 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $534,000 | -18.1% | 81,148 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $652,000 | +30.7% | 81,148 | -8.4% | 0.00% | +100.0% |
Q3 2017 | $499,000 | -47.4% | 88,548 | 0.0% | 0.00% | -66.7% |
Q2 2017 | $949,000 | -10.0% | 88,548 | +5.2% | 0.00% | 0.0% |
Q1 2017 | $1,055,000 | -25.8% | 84,148 | +6.8% | 0.00% | -25.0% |
Q4 2016 | $1,421,000 | -66.4% | 78,824 | -53.7% | 0.00% | -33.3% |
Q3 2016 | $4,232,000 | +178.1% | 170,242 | +119.7% | 0.01% | +20.0% |
Q2 2016 | $1,522,000 | +2278.1% | 77,476 | +1584.3% | 0.01% | – |
Q1 2016 | $64,000 | -22.9% | 4,600 | 0.0% | 0.00% | – |
Q4 2015 | $83,000 | -4.6% | 4,600 | 0.0% | 0.00% | – |
Q3 2015 | $87,000 | -12.1% | 4,600 | 0.0% | 0.00% | – |
Q2 2015 | $99,000 | -3.9% | 4,600 | 0.0% | 0.00% | – |
Q1 2015 | $103,000 | +39.2% | 4,600 | 0.0% | 0.00% | – |
Q4 2014 | $74,000 | -51.3% | 4,600 | -54.0% | 0.00% | -100.0% |
Q3 2014 | $152,000 | +10.1% | 10,000 | 0.0% | 0.00% | – |
Q2 2014 | $138,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DELTEC ASSET MANAGEMENT LLC | 2,159,164 | $32,798,000 | 7.35% |
Senvest Management, LLC | 4,515,935 | $68,597,000 | 6.42% |
Broadfin Capital, LLC | 2,313,702 | $35,145,000 | 3.68% |
HAYS ADVISORY LLC | 512,820 | $7,790,000 | 1.03% |
Ghost Tree Capital, LLC | 120,000 | $1,823,000 | 0.99% |
EMERALD MUTUAL FUND ADVISERS TRUST | 647,096 | $9,829,000 | 0.94% |
TURNER INVESTMENTS LLC | 817,177 | $12,413,000 | 0.74% |
EMERALD ADVISERS, LLC | 681,346 | $10,350,000 | 0.62% |
TSP Capital Management Group, LLC | 86,300 | $1,311,000 | 0.60% |
PERKINS CAPITAL MANAGEMENT INC | 38,500 | $585,000 | 0.49% |